In carrying on her late husband's tradition of feeding wildlife, columnist Juliet Taylor realizes that her actions are a way of honoring him.

An inflammatory sugar molecule produced by certain gut bacteria may play a key role in driving ALS, a study found.

ALS ONE will join the ALS Network to expand ALS research efforts, improve patient services, and strengthen nationwide ...

A dream in the night takes columnist Kristin Neva back to when she and her husband, Todd, were free from ALS hanging over their heads.

A bipartisan team of U.S. lawmakers has reintroduced the ALS Better Care Act, aimed at improving access to quality medical ...

Scientists developed a technique to grow cells that control voluntary movement, a discovery that could aid ALS and spinal ...

The rollator industry is overdue for a transformation, says columnist Dagmar Munn, a longtime user of the device who is living with ALS.

A study is exploring why athletes, first responders, and other high performers face an increased risk of developing ALS.

Half of the planned 200 ALS patients have joined Medicinova’s expanded access program evaluating the experimental drug MN-166 ...

Origami is collaborating with Ipsen to develop molecules designed to remove or correct abnormal proteins in neurodegenerative diseases.

The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.

Coya Therapeutics raised $11.1 million to support manufacturing scale-up for its experimental ALS therapy, COYA 302.